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Previously, we evaluated the effect of the immunobiotic strain Lactobacillus rhamnosus
CRL1505 on the transcriptomic response of porcine intestinal epithelial (PIE) cells
triggered by the challenge with the Toll-like receptor 3 (TLR-3) agonist poly(I:C) and
successfully identified a group of genes that can be used as prospective biomarkers
for the screening of new antiviral immunobiotics. In this work, several strains of
lactobacilli were evaluated according to their ability to modulate the expression of IFNα,
IFNβ, RIG1, TLR3, OAS1, RNASEL, MX2, A20, CXCL5, CCL4, IL-15, SELL, SELE,
EPCAM, PTGS2, PTEGES, and PTGER4 in PIE cells after the stimulation with poly(I:C).
Comparative analysis of transcripts variations revealed that one of the studied bacteria,
Lactobacillus plantarum MPL16, clustered together with the CRL1505 strain, indicating
a similar immunomodulatory potential. Two sets of in vivo experiments in Balb/c mice
were performed to evaluate L. plantarum MPL16 immunomodulatory activities. Orally
administered MPL16 prior intraperitoneal injection of poly(I:C) significantly reduced the
levels of the proinflammatory mediators tumor necrosis factor α (TNF-α), interleukin 6
(IL-6), and IL-15 in the intestinal mucosa. In addition, orally administered L. plantarum
MPL16 prior nasal stimulation with poly(I:C) or respiratory syncytial virus infection
significantly decreased the levels of the biochemical markers of lung tissue damage.
In addition, reduced levels of the proinflammatory mediators TNF-α, IL-6, and IL-8 were
found in MPL16-treated mice. Improved levels of IFN-β and IFN-γ in the respiratory
mucosa were observed in mice treated with L. plantarum MPL16 when compared to
control mice. The immunological changes induced by L. plantarum MPL16 were not
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different from those previously reported for the CRL1505 strain in in vitro and in vivo
studies. The results of this work confirm that new immunobiotic strains with the ability of
stimulating both local and distal antiviral immune responses can be efficiently selected
by evaluating the expression of biomarkers in PIE cells.
Keywords: porcine intestinal epithelial cells, TLR3, Lactobacillus rhamnosus CRL1505, Lactobacillus plantarum
MPL16, antiviral response, respiratory immunity
INTRODUCTION
More than a third of child deaths worldwide are attributed to
malnutrition and its profound impact on the immune system
and the host resistance to infections. In this sense, pneumonia
and diarrhea remain the leading causes of death of children.
Together, these two infectious diseases account for 29% of
all deaths of children younger than 5 years and result in
the loss of 2 million young lives annually (1). In 2009, the
World Health Organization (WHO) separately published two
strategies for the control of pneumonia and diarrhea. Since these
strategies were implemented globally, it has been recognized
that pneumonia and diarrhea could be treated more effectively
in a coordinated manner. Thus, WHO-UNICEF published in
2013 an Integrated Global Action Plan for the Prevention
and Control of Pneumonia and Diarrhea (GAPPD), which
proposes a cohesive approach to ending deaths from preventable
pneumonia and diarrhea in children (1). The GAPPD proposes
interventions to create healthy environments, promotes practices
to protect children from infectious diseases, and ensures that
all children have access to appropriate preventive and treatment
measures. The document emphasizes the importance of healthy
nutrition to reduce the incidence and severity of pneumonia and
diarrhea simultaneously.
Various clinical trials and studies in animal models have
demonstrated the ability of probiotic lactic acid bacteria
(LAB) with immunomodulatory activities, also known as
immunobiotics, to improve the resistance to intestinal viral
infections (2, 3). Although most of the research related to the
beneficial effect of immunobiotics on the host’s immune system
has focused on the stimulation of intestinal immunity to protect
against viral infections (4), it has also been shown that the oral
administration of some immunobiotics strains can beneficially
modulate not only the local intestinal immunity but also immune
responses in distant mucosal sites such as the respiratory tract
(5, 6). Then, it is believed that appropriate immunobiotic
LAB strains can be effectively used as preventive therapies
to improve antiviral defenses and reduce the complications
from the deregulated inflammatory responses in both the
intestine and the respiratory tract. Therefore, the efficient
selection of immunobiotic strains that orally administered
are capable of favorably modulating intestinal and respiratory
antiviral immunity could contribute to reducing the risk of
viral infections, having a simultaneous impact on resistance to
pneumonia and diarrhea.
Lactobacillus rhamnosus CRL1505, orally administered to
mice, is able to differentially modulate both intestinal (7, 8)
and respiratory (9, 10) antiviral immunity. Moreover, in a
randomized controlled trial conducted in children younger than
5 years, it was demonstrated that the immunobiotic CRL1505
strain is capable to enhance mucosal immunity and reduced the
incidence and severity of intestinal and respiratory infections (2).
Of note, our studies in mice models have clearly shown that
the immunomodulatory capacities of L. rhamnosus CRL1505 are
a strain-specific property because other immunobiotic strains
such as Lactobacillus plantarum CRL1506 can stimulate only the
intestinal immunity after their oral administration (7–10).
It is well known that intestinal epithelial cells (IECs) had
a central role in determining the type of immune response
triggered by antigens in the intestinal mucosa through their
interactions with immune cells (11, 12). In this regard,
studies have reported that immunomodulatory LAB modulate
intestinal immune responses by regulating the functions of IECs
(13). Therefore, we hypothesized that transcriptomic analysis
evaluating the effect of L. rhamnosus CRL1505 and L. plantarum
CRL1506 on IECs could bring valuable information about
their capacity of modulating the intestinal innate antiviral
immune response, as well as provide some clues about their
differential ability to influence immunity in the respiratory
tract. By using porcine intestinal epithelial (PIE) cells that
express the pattern recognition receptor (PRR) Toll-like receptor
3 (TLR-3) and respond to poly(I:C) stimulation (14, 15);
we studied the similarities and differences of L. rhamnosus
CRL1505 and L. plantarum CRL1506 in terms of their ability
to modulate the immunotranscriptomic response of epithelial
cells (16). The transcriptional profiling performed in PIE
cells allowed us to characterize the immune and immune-
related genes involved in their response to TLR3 activation,
which included type I interferons (IFNs), antiviral factors,
cytokines, chemokines, adhesion molecules, enzymes involved in
prostaglandin biosynthesis, PRRs, and negative regulators of the
TLR signaling pathway. In addition, we were able to confirm
that the CRL1505 and CRL1506 strains differently regulated
the immunotranscriptomic response of poly(I:C)-challenged
PIE cells (16). Quantitative and qualitative differences in the
expression of immune and immune-related genes in PIE cells
were found when L. rhamnosus CRL1505 and L. plantarum
CRL1506 treatments were compared. Moreover, the comparative
analysis of the effect of the two strains allowed us to identify a
group of genes that could be used as potential biomarkers for the
efficient selection of new antiviral immunobiotics in PIE cells,
which could beneficially influence both the intestinal and the
respiratory antiviral immunity.
In this work, we tested this hypothesis by evaluating
the influence of several immunomodulatory and non-
immunomodulatory lactobacilli strains in the expression of
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IFNα, IFNβ, RIG1, TLR3, OAS1, RNASEL, MX2, A20, CXCL5,
CCL4, IL-15, SELL, SELE, EPCAM, PTGS2, PTEGES, and
PTGER4 in poly(I:C)-challenged PIE cells and by studying
in vivo the effect of orally administered lactobacilli on the
intestinal and respiratory antiviral innate immune responses.
MATERIALS AND METHODS
PIE Cells
The PIE cell line was originally derived from intestinal
epithelia isolated from an unsuckled neonatal swine (17).
Porcine intestinal epithelial cells are intestinal non-transformed
cultured cells that assume a monolayer with a cobblestone
and epithelial-like morphology and with close contact
between cells during culture (14, 17, 18). Porcine intestinal
epithelial cells were maintained in Dulbecco modified eagle
medium (DMEM) (Invitrogen Corporation, Carlsbad, CA,
United States) supplemented with 10% fetal calf serum,
100 mg/mL streptomycin and 100 U/mL penicillin at 37◦C in an
atmosphere of 5% CO2 (16, 18–20).
Microorganisms
Lactobacillus rhamnosus CRL1505, L. plantarum CRL1506,
L. rhamnosus CRL576, and L. plantarum CRL681 belong to
CERELA Culture Collection; L. rhamnosus IBL07 belongs to the
Infection Biology Laboratory of IMMCA-CONICET-UNT and
was kindly given by Dr. Vizoso-Pinto. Lactobacillus plantarum
MPL16 belongs to the Food and Feed Immunology Group
Culture Collection, These strains were grown in Man–Rogosa–
Sharpe broth at 37◦C. For the in vitro immunomodulatory assays,
overnight cultures were harvested by centrifugation, washed
three times with sterile phosphate-buffered saline (PBS), counted
in a Petroff–Hausser counting chamber, and resuspended
in DMEM until use.
Immunomodulatory Effect of Lactobacilli
in PIE Cells
The study of the immunomodulatory capacity of lactobacilli was
performed in PIE cells as described previously (15, 16, 18, 20).
Porcine intestinal epithelial cells were seeded at 3 × 104 cells per
well in 12-well type I collagen-coated plates (Sumitomo Bakelite
Co., Tokyo, Japan) and cultured for 3 days. After changing
medium, lactobacilli (5 × 108 cells/mL) were added, and 48 h
later, each well was washed vigorously with medium at least
three times to eliminate all stimulants. Then cells were stimulated
with poly(I:C) (60 µg/mL) for 12 h for reverse transcription–
polymerase chain reaction (RT-PCR) studies.
Quantitative Expression Analysis by
Two-Step Real-Time Quantitative PCR
Two-step real-time quantitative PCR (qPCR) was performed
to characterize the expression of selected genes in PIE cells as
described previously (16). TRIzol reagent (Invitrogen) was used
for total RNA isolation from each PIE cell sample, and Quantitect
RT kit (Qiagen, Tokyo, Japan) was used for the synthesis of all
cDNAs according to the manufacturer’s recommendations. Real-
time qPCR was carried out using a 7300 real-time PCR system
(Applied Biosystems, Warrington, United Kingdom) and the
Platinum SYBR green qPCR SuperMix uracil-DNA glycosylase
with 6-carboxyl-X-rhodamine (ROX) (Invitrogen). The primers
used for the study of IFNα, IFNβ, RIG1, TLR3, OAS1, RNASEL,
MX2, A20, CXCL5, CCL4, IL-15, SELL, SELE, EPCAM, PTGS2,
PLA2G4A, PTEGES, and PTGER4 expressions in this study were
described before (16, 20, 21). The PCR cycling conditions were
2 min at 50◦C, followed by 2 min at 95◦C, and then 40 cycles of
15 s at 95◦C, 30 s at 60◦C, and 30 s at 72◦C. The reaction mixtures
contained 5 µL of sample cDNA and 15 µL of master mix,
which included the sense and antisense primers. According to the
minimum information for publication of quantitative real-time
PCR experiments guidelines, β-actin was used as a housekeeping
gene because of its high stability across porcine various tissues
(14, 15, 21). Expression of β-actin was used to normalize cDNA
levels for differences in total cDNA levels in the samples.
Animals, Feeding Procedures, and
Poly(I:C) Challenge
Male 6-week-old BALB/c mice were obtained from the closed
colony kept at CERELA-CONICET. Animals were housed
in plastic cages in a controlled atmosphere (22◦C ± 2◦C
temperature, 55% ±2% humidity) with a 12-h light/dark cycle.
Lactobacilli were orally administered to different groups of mice
for five consecutive days at a dose of 108 cells/mouse per day in
the drinking water (22, 23). The treated groups and the untreated
control mice were fed a conventional balanced diet ad libitum.
Two sets of experiments were performed in treated and
control mice. In the first set of experiments, mice were challenged
by the intraperitoneal route with 100 µL of PBS containing 30 µg
poly(I:C) according to our previous publication (8). Biochemical
markers of injury as well as intestinal cytokines’ concentrations
were evaluated 2 days after poly(I:C) administration as described
below. In the second set of experiments, mice were lightly
anesthetized, and 100 µL of PBS, containing 250 µg poly(I:C)
(equivalent to 10 mg/kg body weight), was administered via the
nares according to our previous publication (7). Mice received
three doses of poly(I:C) with 24-h rest period between each
administration.
Respiratory Syncytial Virus Infection
Infection with human respiratory syncytial virus (RSV) strain
A2 was performed as described previously (9). Briefly, RSV was
grown in Vero cells for 3 h at 37◦C, 5% CO2 at multiplicity of
infection of 1 in 5 mL of DMEM. After cell lysis, virus supernatant
was sucrose density gradient purified and stored in 30% sucrose
at −80◦C. For infection, mice were lightly anesthetized with
isoflurane and intranasally challenged with 3.1 × 106 plaque
forming units (PFU) of RSV (9).
For the evaluation of viral infection, the RSV immunoplaque
assay was performed (9). In brief, lung tissue was removed
from mice, homogenized using a pellet pestle, and centrifuged at
2,600× g for 10 min at 4◦C to clarify supernatant. Serial dilutions
of lung tissue–clarified supernatants were added into fresh Vero
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cells monolayers and incubated at 37◦C, 5% CO2 for 3 h. All
samples were run in triplicate. After incubation and removal
of supernatant, 1 mL of fresh DMEM medium containing
10% fetal bovine serum, 0.1% penicillin-streptomycin, and
0.001% ciprofloxacin was added to monolayers. When extensive
syncytia developed, monolayers were fixed with 1 mL of ice-cold
acetone:methanol (60:40). Then, wells were treated with primary
RSV anti-F (clones 131-2A; Chemicon, Temecula, CA, United
States) and anti-G{mouse monoclonal [8C5 (9B6)] to RSV
glycoprotein; Abcam} antibodies for 2 h, followed by secondary
horseradish peroxidase anti–mouse immunoglobulin antibody
(anti–mouse immunoglobulin G, horseradish peroxidase–linked
antibody #7076; Cell Signaling Technology, Danvers, MA, United
States) for 1 h. Plates washed twice with PBS containing 0.5%
Tween 20 (Sigma, St. Louis, MO, United States) after each
antibody incubation step. Individual plaques were developed
using a DAB substrate kit (ab64238; Abcam, Cambridge, United
Kingdom) following the manufacturer’s specifications. Results
were expressed as log10 PFU/g of lung.
Ethics Statement
Animals were housed in plastic cages and environmental
conditions were kept constant, in agreement with the standards
for animal housing. Animal welfare was in charge of researchers
and special staff trained in animal care and handling at CERELA.
The minimal number of animals required for an appropriate
statistical analysis was calculated with the help of the Biostatistics
Laboratory of CERELA.
Animals were housed individually during the experiments.
All efforts were made to minimize the number of animals and
their suffering. Animal health and behavior were monitored
twice a day. Animals were euthanized immediately after the time
point was reached by using xylazine and ketamine. No signs of
discomfort or pain and no deaths were observed before mice
reached the endpoints.
All experiments were carried out in compliance with the
Guide for Care and Use of Laboratory Animals and approved
by the Ethical Committee of Animal Care at CERELA, Argentina
(protocol no. BIOT-CRL/14 and BIOT-CRL/11) (7, 8).
Markers of Injury
Lactate dehydrogenase (LDH) and aspartate aminotransferase
(AST) activities were determined in the serum to evaluate general
toxicity of poly(I:C) in mice challenged by the intraperitoneal
injection. Blood samples were obtained through cardiac puncture
under anesthesia. LDH and AST activities, expressed as units per
liter of serum, were determined by measuring the formation of
the reduced form of nicotinamide adenine dinucleotide using
the Wiener reagents and procedures (Wiener Lab, Buenos Aires,
Argentina) (8).
Albumin content, a measure to quantitate increased
permeability of the bronchoalveolar–capillarity barrier, and LDH
activity, an indicator of general cytotoxicity, were determined
in bronchoalveolar lavage (BAL) fluid. Bronchoalveolar lavage
samples were obtained as described previously (7, 15). Briefly,
the trachea was exposed and intubated with a catheter, and
two sequential lavages were performed by injecting sterile PBS
in each mouse lung. The recovered fluid was centrifuged for
10 min at 900 × g; the pellet was discarded, and the fluid was
frozen at −70◦C for subsequent analyses. Albumin content
was determined colorimetrically based on albumin binding to
bromocresol green using an albumin diagnostic kit (Wiener
Lab). Lactate dehydrogenase activity, expressed as units per liter
of BAL fluid, was determined by using the Wiener reagents and
procedures (Wiener Lab) (7).
Lung wet-to-dry weight ratio was measured as previously
described (7, 9). Wet-to-dry weight ratio was calculated as an
index of intrapulmonary fluid accumulation, without correction
for blood content.
Cytokine Concentrations
Serum and BAL samples were obtained as described before (9).
Briefly, blood samples were obtained by cardiac puncture under
anesthesia. For BAL samples, the trachea was exposed surgically
and intubated with a catheter. A small incision was made in
the trachea, and two sequential lavages were performed in each
mouse by injecting sterile PBS with 1% heparin. The recovered
fluid was centrifuged for 10 min at 300 revolutions/min, and
the supernatant was recovered. Intestinal fluid samples were
obtained according to our previous publication (8). Briefly, the
small intestine was flushed with 5 mL of PBS, and the fluid was
centrifuged (10,000 × g, 4◦C 10 min) to separate particulate
material. The serum, BAL and intestinal supernatant samples
were kept frozen at−80◦C until use.
Tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), IL-
10, IL-15, IFN-β, and IFN-γ concentrations in serum, intestinal
fluid, and BAL samples were measured with commercially
available enzyme-linked immunosorbent assay technique kits
following the manufacturer’s recommendations (R&D Systems,
Minneapolis, MN, United States).
Statistical Analysis
Statistical analyses were performed using GLM and REG
procedures available in the SAS computer program (SAS,
1994). Comparisons between mean values were carried out
using one-way analysis of variance and Fisher least significant




Immunotranscriptome Changes in PIE
Cells by Lactobacilli
Previously, we analyzed the effect of L. rhamnosus CRL1505 and
L. plantarum CRL1506 on the innate immune response of PIE
cells after the challenge with poly(I:C) by using a transcriptomic
approach (16). From that study, we were able to select a set
of potential biomarkers that would allow us to efficiently select
new immunobiotic strains with antiviral capabilities including
IFNα, IFNβ, RIG1, TLR3, OAS1, RNASEL, MX2, A20, CXCL5,
CCL4, IL-15, SELL, SELE, EPCAM, PTGS2, PLA2G4A, PTEGES,
and PTGER4. Then, in order to validate this assumption,
PIE cells were stimulated with different lactobacilli including
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immunomodulatory (L. rhamnosus CRL1505, L. plantarum
CRL1506, L. rhamnosus IBL07, and L. plantarum MPL16) (8,
16, 24, 25) and non-immunomodulatory (L. rhamnosus CRL576
and L. plantarum CRL681) strains and then challenged with
poly(I:C). The expression of the biomarkers was then evaluated.
When the expressions of type I IFNs, antiviral factors, and
the negative regulator A20 were analyzed, a strain-dependent
effect was observed (Figure 1, Supplementary Figure S1). The
CRL1505, CRL1506, and MPL16 strains were highly efficient
for increasing IFNα, MX2, OAS1, and TLR3 expression. In
addition, L. rhamnosus CRL1505, and L. plantarum MPL16
were the lactobacilli with the highest capacity to increase the
expression of IFNβ and RNASEL (Figure 1). Lactobacillus
rhamnosus IBL07 was capable of enhancing the mRNA levels
of IFNα, IFNβ, OAS1, TLR3, and RNASEL, but it was not as
efficient as the CRL1505 and MPL16 strains. RIG-1 was enhanced
by all the immunomodulatory strains CRL1505, CRL1506,
IBL027, and MPL16, whereas the non-immunomodulatory
strains CRL681 and CRL576 were not able to induce changes
in the expression of type I IFNs or antiviral factors (Figure 1,
Supplementary Figure S1). Lactobacillus rhamnosus CRL1505,
L. plantarum CRL1506, and L. plantarum MPL16 significantly
reduced the expression of A20 in poly(I:C)-challenged PIE
cells, whereas no effect was observed for the other studied
strains (Figure 1).
The CRL1505 and MPL16 strains were highly efficient in
enhancing the expression of CCL4, CXCL5, EPCAM, and SELE
(Figure 2). The CRL1506 and IBL027 augmented the expression
of CCL4, but the levels of this mRNA were significantly lower
than in the CRL1505 or MPL16 groups (Figure 2). The four
immunomodulatory strains increased SELL expression, being
L. plantarum MPL16 the most efficient to achieve this effect.
The non-immunomodulatory strains CRL681 and CRL576 were
not able to induce changes in the expression of chemokines
and adhesion molecules (Figure 2). Lactobacillus rhamnosus
CRL1505, L. plantarum CRL1506, and L. plantarum MPL16
significantly reduced the expression of IL-15 in poly(I:C)-
challenged PIE cells, whereas no effect was observed for the other
studied strains (Figure 2).
The expressions of PTGS2, PLA2G4A, and PTEGES
were enhanced, and PTGER4 was reduced by the four
immunomodulatory strains (Supplementary Figure S2).
However, L. rhamnosus CRL1505 and L. plantarum MPL16 were
more efficient than L. plantarum CRL1506 and L. rhamnosus
IBL027 to increase the expression of PTGS2, PLA2G4A,
and PTEGES and reduce PTGER4 in poly(I:C)-challenged
PIE cells. The non-immunomodulatory strains CRL681 and
CRL576 were not able to induce changes in the expression
of the enzymes involved in prostaglandins biosynthesis
(Supplementary Figure S2).
FIGURE 1 | Expression of interferon (IFN)-β, antiviral factors (MX2 and RNASEL), and the negative regulator A20 genes in porcine intestinal epithelial (PIE) cells
treated with Lactobacillus rhamnosus CRL1505, L. rhamnosus IBL027, L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum MPL16, or
L. plantarum CRL681 and challenged with the viral molecular–associated pattern poly(I:C), analyzed by quantitative polymerase chain reaction. Porcine intestinal
epithelial cells with no lactobacilli treatment and stimulated with poly(I:C) were used as controls. The results represent data from three independent experiments.
Letters indicate significant differences (P < 0.05), a < b < c.
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FIGURE 2 | Expression of chemokines [interleukin 15 (IL-15), CCL4, and CXCL5] and adhesion molecules (EPCAM, SELE, and SELL) genes in porcine intestinal
epithelial (PIE) cells treated with Lactobacillus rhamnosus CRL1505, L. rhamnosus IBL027, L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum
MPL16, or L. plantarum CRL681 and challenged with the viral molecular–associated pattern poly(I:C), analyzed by quantitative polymerase chain reaction. Porcine
intestinal epithelial cells with no lactobacilli treatment and stimulated with poly(I:C) were used as controls. The results represent data from three independent
experiments. Letters indicate significant differences (P < 0.05), a < b < c.
FIGURE 3 | Heat map analysis of the differentially regulated genes in porcine intestinal epithelial (PIE) cells treated with Lactobacillus rhamnosus CRL1505,
L. rhamnosus IBL027, L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum MPL16, or L. plantarum CRL681 and challenged with the viral
molecular–associated pattern poly(I:C).
We performed a cluster analysis to depict the transcriptomic
patterns of differentially modulated genes between lactobacilli-
treated and control PIE cells, in order to find the strains
with similar immunomodulatory properties in the context
of TLR3 activation. As shown in Figure 3, the treatments
with immunomodulatory lactobacilli plus poly(I:C) clustered
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together and separated from the non-immunomodulatory
strains. Moreover, L. rhamnosus CRL1505 and L. plantarum
MPL16 were separated from L. plantarum CRL1506 and
L. rhamnosus IBL027. These results indicate that L. plantarum
MPL16 would have the ability to differentially regulate the
immunotranscriptomic response in poy(I:C)-challenged PIE cells
(Supplementary Figure S3) in a way comparable to that
previously reported for L. rhamnosus CRL1505 (16, 20).
Modulation of TLR3-Triggered Intestinal
Immune Response in Mice by
Lactobacilli
Next, we were interested in finding out whether the differences
in the immunomodulatory activities of CRL1505, MPL16,
CRL1506, and IBL027 observed in PIE cells could be also found in
an in vivo model. Then, lactobacilli were given orally to different
groups of mice, and the intestinal cytokine profile was evaluated
before (basal levels) and after the intraperitoneal challenge with
poly(I:C). As observed in Supplementary Figure S4, a strain-
dependent ability in the modulation of the basal levels of
intestinal cytokines was detected. The four immunomodulatory
strains increased the intestinal levels of IFN-β, IFN-γ, and IL-10;
however, L. rhamnosus CRL1505 and L. plantarum MPL16 were
more efficient than the other strains to augment IFN-γ and IL-
10. The non-immunomodulatory strains CRL681 and CRL576
did not modify the levels of intestinal IFN-β. Interestingly,
L. plantarum CRL681 increased the levels of intestinal IFN-γ
and IL-10 (Supplementary Figure S4). All the lactobacilli strains
with the exception of L. rhamnosus CRL576 increased TNF-α,
whereas the CRL1505, MPL16, IBL027, and CRL681 enhanced
the intestinal levels of IL-6 (Supplementary Figure S4). The basal
concentration of IL-15 was under the detection limits in all the
experimental groups (data not shown).
We evaluated the biochemical markers LDH and AST in order
to study the inflammatory damage after poly(I:C) administration
(Figure 4). As we reported previously (8), the intraperitoneal
challenge with poly(I:C) significantly increased LDH and AST
activities in serum samples. The four immunomodulatory
strains decreased serum LDH and AST, whereas the non-
immunomodulatory strains CRL681 and CRL576 did not modify
the levels of those markers (Figure 4).
In addition, the intraperitoneal administration of poly(I:C)
significantly increased the levels of IFN-β; IFN-γ; the
proinflammatory cytokines TNF-α, IL-6, and IL-15; and
the regulatory cytokine IL-10 in the intestinal fluid (Figure 5).
The four immunomodulatory strains were able to enhance
the intestinal levels of IFN-β and IFN-γ after TLR3 activation.
The CRL1505, MPL16, CRL1506, and IBL027 strain were
also capable of significantly reducing the concentrations of
TNF-α, IL-6, and IL-15 and increasing the levels of IL-10 in the
intestine when compared to control mice (Figure 5). Of note,
L. rhamnosus CRL1505 and L. plantarum MPL16 were more
efficient than the other strains to reduce TNF-α and IL-15. The
non-immunomodulatory strains CRL681 and CRL576 did not
modify the levels of IFN-β, IFN-γ, TNF-α, IL-6, IL-15, or IL-10
when compared to controls (Figure 5).
Again, we performed a cluster analysis to depict the
differentially modulated cytokines and injury markers between
lactobacilli-treated and control mice, in order to find the
strains with similar immunomodulatory properties in the in vivo
mice model. As shown in Figure 6, a clear strain-dependent
effect was observed in the ability of lactobacilli to modulate
cytokines before and after poly(I:C) challenge. Interestingly,
L. rhamnosus CRL1505 and L. plantarum MPL16 clustered
together and separated from the other immunomodulatory
strains L. plantarum CRL1506 and L. rhamnosus IBL027. These
results allow us to speculate that L. plantarum MPL16 would
have the ability to differentially regulate the intestinal innate
immune response in poy(I:C)-challenged mice and protect
against the inflammatory damage (Supplementary Figure S5) in
a way comparable to that previously reported for L. rhamnosus
CRL1505 (8).
Modulation of TLR3-Triggered
Respiratory Immune Response in Mice
by Lactobacilli
We have previously reported that orally administered
L. rhamnosus CRL1505 is able to beneficially modulate the
respiratory immune response triggered by TLR3 activation (7)
and improve the resistance against influenza virus (10) and RSV
(9). We also showed that the capacity of orally administered
CRL1505 strain to modulate immunity in distal mucosal sites
is not sheared by the immunomodulatory strain L. plantarum
CRL1506. Then, taking into considerations the similarities
found in this work between the CRL1505 and MPL16 strains,
we were interested in finding out whether orally administered
L. plantarum MPL16 was able to influence respiratory tract
immunity. For this purpose, lactobacilli were given orally
to different groups of mice, and the serum and respiratory
cytokine profile was evaluated before (basal levels) and after
the nasal challenge with poly(I:C). The changes in the profile of
cytokines induced in the BAL (Supplementary Figure S6) and
serum (Supplementary Figure S7) by lactobacilli indicated a
clear strain-dependent effect. When the levels of the different
cytokines were analyzed in BAL, it was shown that only
L. rhamnosus CRL1505 and L. plantarum MPL16 enhanced the
concentrations of IFN-β. In addition, CRL1505, MPL16 and
IBL027 increased the basal levels of IFN-γ and IL-10. However,
L. rhamnosus IBL027 was less efficient than the CRL1505
and MPL16 to induce the up-regulation of those cytokines
(Supplementary Figure S6). The basal levels of respiratory
TNF-α were increased by L. rhamnosus CRL1505, L. plantarum
MPL16, and L. plantarum CRL1506, whereas the CRL681 and
CRL576 treatments induced no changes in any of the cytokines
evaluated in the respiratory tract (Supplementary Figure S6).
All the immunomodulatory strains were capable of enhancing
the concentrations of IFN-β, IFN-γ, TNF-α, and IL-10 in
serum when compared to controls. However, L. rhamnosus
CRL1505 and L. plantarum MPL16 were more efficient than
the other immunomodulatory strains to increase the basal levels
of serum IFN-γ, TNF-α, and IL-10. Lactobacillus rhamnosus
CRL576 and L. plantarum CRL681 did not induce significant
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FIGURE 4 | Levels of serum injury markers [lactate dehydrogenase (LDH) and aspartate aminotransferase (AST)] in mice orally treated with Lactobacillus rhamnosus
CRL1505, L. rhamnosus IBL027, L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum MPL16, or L. plantarum CRL681 (108 cells/mouse per
day for five consecutive days) and then challenged by the intraperitoneal route with 30 µg of the viral molecular–associated pattern poly(I:C). Mice with no lactobacilli
treatment and challenged with poly(I:C) were used as controls. Serum injury markers were evaluated on day 2 after poly(:C) administration. The results represent data
from three independent experiments (n = 6 per group). Letters indicate significant differences (P < 0.05), a < b < c.
FIGURE 5 | Levels of intestinal interferons (IFN-β and IFN-γ), proinflammatory cytokines [TNF-α and interleukin 6 (IL-6)] and IL-10 in mice orally treated with
Lactobacillus rhamnosus CRL1505, L. rhamnosus IBL027, L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum MPL16, or L. plantarum
CRL681 (108 cells/mouse per day for 5 consecutive days) and then challenged by the intraperitoneal route with 30 µg of the viral molecular–associated pattern
poly(I:C). Mice with no lactobacilli treatment and challenged with poly(I:C) were used as controls. Immune factors were evaluated on day 2 after poly(:C)
administration. The results represent data from three independent experiments (n = 6 per group). Letters indicate significant differences (P < 0.05), a < b < c.
changes in serum cytokines when compared to controls
(Supplementary Figure S7).
We also evaluated the levels of the biochemical markers
albumin and LDH in BAL as indicators of lung injury
(7, 9, 10). The nasal challenge of mice with poly(I:C)
significantly altered lungs function and induced lung injuries
as demonstrated by the increased levels of BAL albumin and
LDH (Figure 7), reflecting alteration of the alveolar–capillary
barrier and local cellular damage. Only L. rhamnosus CRL1505
and L. plantarum MPL16 treatments were able to significantly
reduce the levels of BAL LDH and albumin when compared to
controls (Figure 7).
The nasal administration poly(I:C) significantly increased
serum (Supplementary Figure S8) and respiratory (Figure 8)
levels of IFN-β, IFN-γ, TNF-α, and IL-10. Lactobacillus
rhamnosus CRL1505 and L. plantarum MPL16 enhanced the
levels of IFN-β and IFN-γ in both serum and BAL, whereas
L. rhamnosus IBL027 was capable of increasing only BAL
IFN-γ. The four immunomodulatory strains were capable of
reducing serum and BAL levels of TNF-α, however; the CRL1505
and MPL16 strains were more effective to down-regulate this
inflammatory cytokine in the respiratory tract (Figure 8). In
addition, the four immunomodulatory strains increased IL-10
in serum (Supplementary Figure S8), but only L. rhamnosus
CRL1505 and L. plantarum MPL16 enhanced the levels of this
immunoregulatory cytokine in the respiratory tract (Figure 8).
We performed a cluster analysis to depict the differentially
modulated serum and BAL cytokines and lung injury markers
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FIGURE 6 | Heat map analysis of the differentially regulated intestinal immune factors and serum injury markers before (basal) and after poly(I:C) challenge. Mice
were orally treated with Lactobacillus rhamnosus CRL1505, L. rhamnosus IBL027, L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum MPL16,
or L. plantarum CRL681, and then challenged by the intraperitoneal route with the viral molecular–associated pattern poly(I:C).
FIGURE 7 | Levels of bronchoalveolar lavage (BAL) injury markers [albumin and lactate dehydrogenase (LDH)] in mice orally treated with Lactobacillus rhamnosus
CRL1505, L. rhamnosus IBL027, L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum MPL16, or L. plantarum CRL681 (108 cells/mouse per day
for five consecutive days) and then challenged by the nasal route with 250 µg of the viral molecular–associated pattern poly(I:C) for 3 consecutive days. Mice with no
lactobacilli treatment and challenged with poly(I:C) were used as controls. Bronchoalveolar lavage injury markers were evaluated on day 2 after the last poly(:C)
administration. The results represent data from three independent experiments (n = 6 per group). Letters indicate significant differences (P < 0.05), a < b < c.
between lactobacilli-treated and control mice. As shown in
Figure 9, a clear strain-dependent effect was observed in the
ability of lactobacilli to modulate immunity in the respiratory
tract. Of note, L. rhamnosus CRL1505 and L. plantarum
MPL16 clustered together and separated from the other
immunomodulatory strains. These results allow us to speculate
that L. plantarum MPL16 would have the ability to differentially
regulate the systemic and respiratory innate immune response
in poy(I:C)-challenged mice and protect against the lung
inflammatory damage (Supplementary Figure S9) in a way
comparable to that previously reported for L. rhamnosus
CRL1505 (7).
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FIGURE 8 | Levels of bronchoalveolar lavage (BAL) interferons (IFN-β and IFN-γ), TNF-α, and interleukin 10 (IL-10) in mice orally treated with Lactobacillus
rhamnosus CRL1505, L. rhamnosus IBL027, L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum MPL16, or L. plantarum CRL681 (108
cells/mouse per day for 5 consecutive days) and then challenged by the nasal route with 250 µg of the viral molecular–associated pattern poly(I:C) for three
consecutive days. Mice with no lactobacilli treatment and challenged with poly(I:C) were used as controls. Bronchoalveolar lavage immune factors were evaluated on
day 2 after the last poly(:C) administration. The results represent data from three independent experiments (n = 6 per group). Letters indicate significant differences
(P < 0.05), a < b < c.
Enhancement of the Resistance Against
RSV Infection by L. plantarum MPL16
Finally, we aimed to test whether the oral administration of
L. plantarum MPL16 was able to confer protection against
a respiratory virus challenge. For this purpose, mice were
fed the MPL16 strain and then nasally challenged with RSV.
Lactobacillus rhamnosus CRL1505 and L. plantarum CRL1506
were used as positive and negative controls, respectively,
according to our previous work demonstrating their different
ability to protect against this viral pathogen (9). As shown
in Figure 10, both L. rhamnosus CRL1505 and L. plantarum
MPL16 were equally effective in reducing RSV lung titers,
whereas the CRL1506 strain did not induce changes when
compared to control mice. In addition, the MPL16 and CRL1505
strains significantly reduced the levels of the markers of lung
damage, whereas L. plantarum CRL1506 was not able to
achieve this effect (Figure 10). The levels of respiratory IFN-
β, IFN-γ, TNF-α, and IL-10 were also evaluated after the
challenge with RSV (Figure 11). Both L. rhamnosus CRL1505
and L. plantarum MPL16 enhanced the levels of IFN-β, IFN-
γ, and IL-10 in BAL, whereas L. plantarum CRL1506 was
not capable of increasing these cytokines when compared to
controls. The CRL1506 strain did not induce changes in the
levels of BAL TNF-α when compared to the control group.
The MPL16 and CRL1505 strains significantly increased the
respiratory levels of TNF-α, being L. rhamnosus CRL1505
more effective than L. plantarum MPL16 to achieve this
effect (Figure 11).
DISCUSSION
In middle- and low-income countries, intestinal and respiratory
viral infections are the most common and deadly diseases
in children (26–28). The use of functional foods such as
those containing immunomodulatory probiotic lactobacilli has
been proposed to stimulate the intestinal and the respiratory
immune system, improving the outcome of viral diarrhea
and pneumonia simultaneously. An example of the high
probability of success of this strategy is the “Yogurito
Nutritional Program” implemented in Argentina (2, 29). The
program uses a probiotic yogurt containing the immunobiotic
strain L. rhamnosus CRL1505 to prevent respiratory and
gastrointestinal diseases by enhancing the immunological system
of children attending public schools. Then, the selection of
new immunobiotic strains that have different biotechnological
properties but the same or better immunomodulatory capacities
than L. rhamnosus CRL1505 could enhance the development
of various types of functional foods that could be used
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FIGURE 9 | Heat map analysis of the differentially regulated serum and bronchoalveolar lavage (BAL) immune factors and BAL injury markers before (basal) and after
poly(I:C) challenge. Mice were orally treated with Lactobacillus rhamnosus CRL1505, L. rhamnosus IBL027, L. rhamnosus CRL576, Lactobacillus plantarum
CRL1506, L. plantarum MPL16, or L. plantarum CRL681 and then challenged by the nasal route with the viral molecular–associated pattern poly(I:C) for three
consecutive days.
around the world to reduce the incidence and severity of
intestinal and pulmonary infections caused by viruses. Such
selection, in addition to being efficient, should be performed
using in vitro systems in order to minimize the use of
experimental animals.
In this work, we demonstrated that the study of biomarkers
expression in poly(I:C)-challenged PIE cells is a very effective tool
for the selection of immunobiotics with the ability to modulate
intestinal and respiratory antiviral immunity. The transcriptional
profiling performed in vitro in poly(I:C)-challenged PIE cells
in this work allowed us to select a new immunobiotic strain,
L. plantarum MPL16, with the ability to stimulate in vivo the local
(intestinal) and distal (respiratory) mucosal immune systems.
Lactobacillus rhamnosus CRL1505 and L. plantarum MPL16
similarly modulated gene expression in poly(I:C)-challenged PIE
cells inducing significant increases of both IFN-α and IFN-β and
in the antiviral factors MX2, OAS1, and RNASEL. Our previous
studies in PIE cells showed that rotavirus can be detected by this
cell line through TLR3, inducing the expression of IFN-β and up-
regulating the antiviral genes MxA and RNASEL (15). Moreover,
those studies demonstrated that immunobiotics strains with
the ability to enhance IFN-β, MxA, and RNASEL were also
capable of reducing rotavirus replication. We demonstrated that
immunobiotic strains such as L. rhamnosus CRL1505 (16) and
Bifidobacterium infantis MCC12 (15) increased the expression
of IFN-β and antiviral factors by reducing the expression of
A20. The down-regulation of A20 gene expression in poly(I:C)-
challenged PIE cells results in the improved activation of IRF3
and NF-κB signaling pathways, which increase the expression
of not only IFN-α, IFN-β, MX2, OAS1, and RNASEL but in
addition several other antiviral factors including OASL, MX1,
OAS2, RNASE4, IFIT1, IFIT3, IFIT2, and IFIT5 (Supplementary
Figure S3) (16). The in vivo experiments in mice performed
here also demonstrated that L. plantarum MPL16 is able to
enhance the intestinal levels of IFN-β. Moreover, MPL16-treated
mice also showed higher levels of intestinal IFN-γ as observed
by L. rhamnosus CRL1505. It was reported that infection with
rotavirus in suckling mice induces a significant up-regulation
of different types of IFNs in the intestine including IFN-γ by
T cells and type I IFNs by dendritic cells (DCs) and IECs
(30). Interferons binding to their cognate cell surface receptors
activate positive feedback loops that amplify the expression of
IFNs as well as more than 300 different IFN-stimulated genes
(31). This IFNs release then efficiently amplify the expression
of antiviral proteins targeting a variety of viral replication steps
in uninfected bystander cells. It was also shown in in vitro
studies that the addition of purified exogenous IFNs after
rotavirus infection of human IECs does not significantly hamper
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FIGURE 10 | Lung respiratory syncytial virus (RSV) titers, lung wet-to-dry ratio, and levels of bronchoalveolar lavage (BAL) injury markers [albumin and lactate
dehydrogenase (LDH)] in mice orally treated with Lactobacillus rhamnosus CRL1505, Lactobacillus plantarum CRL1506, or L. plantarum MPL16 (108 cells/mouse
per day for five consecutive days) and then challenged by the nasal route with RSV. Mice with no lactobacilli treatment and infected with RSV were used as controls.
Respiratory syncytial virus titers and injury markers were evaluated on day 2 after viral infection. The results represent data from three independent experiments
(n = 6 per group). Letters indicate significant differences (P < 0.05), a < b < c.
viral replication; however, IFN treatment of cells prior to viral
challenge is required to achieve an efficient restriction of rotavirus
replication (32).
The excessive activation of the inflammatory response or the
failure in the mechanisms that control it significantly contributes
to the injury of the infected tissue during viral infections.
Intestinal epithelial cells produce a variety of cytokines and
chemokines in response to the viral attack, including IL-6, IL-8,
TNF-α, and granulocyte-macrophage colony-stimulating factor.
The production of those inflammatory factors is important
for the protection against the viral infection through their
direct antiviral effects (33) or the recruitment and activation of
phagocytes (34). However, infiltration of immune cells to the
intestinal mucosa can contribute to the local damage mediated
by the inflammatory and oxidative stress (35). In addition, it
was reported that purified dsRNA from rotavirus is able to
induce severe intestinal damage in mice through the activation of
TLR3 signaling pathway (36). Moreover, it was also demonstrated
that the intraperitoneal administration of the synthetic dsRNA
poly(I:C) to mice mimics the inflammatory intestinal immune
response elicited by rotavirus and induce mucosal erosion, villous
atrophy, intestinal wall attenuation, and diarrhea (8, 36, 37).
Interestingly, it was shown that the intestinal damage triggered by
dsRNA-TRL3 interaction is mediated by the increased expression
of IL-15 and retinoic acid early inducible 1 (RAE1) in IECs, which
induce the activation of CD3+NK1.1+CD8αα+ intraepithelial
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FIGURE 11 | Levels of bronchoalveolar lavage (BAL) interferons (IFN-β and IFN-γ), TNF-α, and interleukin 10 (IL-10) in mice orally treated with Lactobacillus
rhamnosus CRL1505, Lactobacillus plantarum CRL1506, or L. plantarum MPL16 (108 cells/mouse per day for five consecutive days) and then challenged by the
nasal route with RSV. Mice with no lactobacilli treatment and infected with RSV were used as controls. Immune markers were evaluated on day 2 after viral infection.
The results represent data from three independent experiments (n = 6 per group). Letters indicate significant differences (P < 0.05), a < b < c.
lymphocytes (IELs) and promote epithelial destruction through
the RAE1–NKG2D interaction (Supplementary Figure S5) (38).
We reported previously that L. rhamnosus CRL1505 is able
to significantly reduce the expression of IL-15 and RAE1 in
poly(I:C)-challenged PIE cells (16) and to reduce the levels
of intestinal TNF-α and IL-15 and diminish the gut damage
mediated by CD3+NK1.1+CD8αα+ IELs in mice after TLR3
activation (8). Here, we found that L. plantarum MPL16 is
able to modulate the cytokine profile expression triggered by
TLR3 activation in PIE cells as well as in mice intestinal
mucosa, in a way similar to that observed for the CRL1505
strain. Then, it is tempting to speculate that L. plantarum
MPL16 would have the ability to beneficially regulate intestinal
inflammation in the context of TLR3 activation; however,
more detailed studies using viral challenges are necessary to
demonstrate this effect.
Our results allow us to speculate that L. plantarum MPL16
would be capable to modulate IECs innate immune response,
improve the resistance to rotavirus infection, and reduce
the severity of inflammatory-mediated damage, as we have
previously demonstrated in vitro (16, 20), in vivo (8), and in
clinical trials (2, 29) for the CRL1505 strain.
We also demonstrated here that orally administered
L. plantarum MPL16 is able to differentially modulate the
respiratory antiviral immune response. We reported previously
that the improvement of IFN-β production by CD11c+SiglecF+
alveolar macrophages and IFN-γ by CD3+CD4+ T cells is related
to the ability of immunobiotic treatments to enhance resistance
to respiratory virus (39, 40), in line with studies demonstrating
that these immune cell populations are the main producer of
IFNs during pulmonary viral infections (36, 37). The increased
levels of respiratory IFN-γ and IFN-β found in L. plantarum
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MPL16–treated mice correlated with the improved resistance of
mice to RSV infection. On the other hand, we have extensively
used a mice experimental model of lung inflammation based
on the nasal administration of poly(I:C) in order to mimic
the respiratory innate antiviral immune response triggered by
RSV and to evaluate the beneficial effects of immunobiotic
bacteria (7, 9, 10, 39, 40). The respiratory priming with the TLR3
agonist induces a marked inflammatory damage characterized
by impaired alveolar–capillary barrier function and epithelial cell
death as well as increased levels of TNF-α, IL-6, IL-8, and MCP-1.
Prominent improvements of the IL-8, MIP-1, RANTES, MCP-1,
TNF-α, and IL-6 have been reported in both experimentally
RSV-infected mice and naturally RSV-infected children (41). The
increase in the respiratory levels of those inflammatory factors,
especially TNF-α, contributes to clearance of the virus during
the early stages of RSV infection; however, their continued
production exacerbates lung injuries during the late stages
of infection (41, 42). Then, the appropriate regulation of the
respiratory immune response is also essential for the protection
of RSV-infected hosts. In this regard, it was demonstrated
that IL-10 has a crucial role in regulating the severity of RSV
infection (42, 43). The deficiency of IL-10 does not affect RSV
load in lungs, but significantly enhances the inflammatory cells
influx into the lung, promotes lung damage, and increases
weight loss of infected mice (42, 43). The results of this work
demonstrated that orally administered L. plantarum MPL16 is
able to reduce the levels of inflammatory factors, increase IL-10,
and significantly diminish the markers of lung tissue damage
after the nasal administration of poly(I:C). Moreover, we also
demonstrated here that orally administered L. plantarum MPL16
significantly reduced the respiratory injury markers after RSV
challenge and differentially modulated the levels of respiratory
proinflammatory and anti-inflammatory cytokines induced by
the viral infection. Those effects were similar to the previously
described for the CRL1505 strain (Supplementary Figure S9)
(7, 9, 10, 39).
The results of this work confirm that new immunobiotics
strains with the ability of stimulating both local and distal
antiviral immune responses when orally administered can be
efficiently selected by evaluating the expression of appropriate
biomarkers of the transcriptomic profile of poly(I:C)-challenged
PIE cells. The comparison of the transcriptomic patterns
of differentially modulated genes in PIE cells treated with
different lactobacilli allowed us to select the MPL16 strain that
clustered together with the immunobiotic strain L. rhamnosus
CRL1505, which has been proved to differentially modulate
the intestinal and the respiratory antiviral responses and
protect against enteric and respiratory viruses (2, 7, 9, 10).
The in vivo studies performed here conclusively demonstrated
that L. plantarum MPL16 modulated the profiles of intestinal,
serum, and respiratory cytokines; reduced the inflammatory
damage triggered by TLR3 activation in both the intestinal
and respiratory mucosa; and improved the resistance to RSV
infection. The immunological changes induced by L. plantarum
MPL16 were not different from those previously reported for
the CRL1505 strain. Further mechanistic studies evaluating
comparatively the effects of CRL1505 and MPL16 strains in
different immune cell populations such as DCs and macrophages,
as well as more detailed molecular and genomic characterization
of both lactobacilli strains, could contribute significantly to the
understanding of the molecular mechanisms involved in the
ability of immunobiotics to stimulate distant mucosal sites such
as the respiratory tract.
Of note, the biotechnological properties of the two strains
are different. Whereas L. rhamnosus CRL1505 has been used
mainly in the development of dairy functional products (2, 44),
the MPL16 strain has shown a remarkable ability to growth
and ferment wakame (Undaria pinnatifida) that is the most
popular and economically important edible brown algae in Asian
countries (24, 45). Then, the different biotechnological properties
of L. plantarum MPL16 could potentiate the development of
non-dairy functional foods or feeds with the ability to improve
antiviral immunity in the intestine and the respiratory tract.
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FIGURE S1 | Expression of interferon (IFN)-α, and antiviral factors (TLR3, RIG-1
and OAS1) genes in porcine intestinal epithelial (PIE) cells treated with
Lactobacillus rhamnosus CRL1505, L. rhamnosus IBL027, L. rhamnosus
CRL576, Lactobacillus plantarumC RL1506, L. plantarum MPL16, or L. plantarum
CRL681 and challenged with the viral molecular associated pattern poly(I:C),
analyzed by qPCR. PIE cells with no lactobacilli treatment and stimulated with
poly(I:C) were used as controls. The results represent data from three independent
experiments. Letters indicate significant differences (P < 0.05), a < b < c.
FIGURE S2 | Expression of genes involved in prostaglandins biosynthesis
(PTGS2, PLA2G4A, PTGER4 and PTGES) in porcine intestinal epithelial (PIE) cells
treated with Lactobacillus rhamnosus CRL1505, L. rhamnosus IBL027,
L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum MPL16,
or L. plantarum CRL681 and challenged with the viral molecular associated
pattern poly(I:C), analyzed by qPCR. PIE cells with no lactobacilli treatment and
stimulated with poly(I:C) were used as controls. The results represent data from
three independent experiments. Letters indicate significant differences
(P < 0.05), a < b < c.
FIGURE S3 | Global overview of the signaling pathways and immune genes
differentially regulated in PIE cells treated with L. rhamnosus CRL1505 or
L. plantarum MPL16 and challenged with poly(I:C). Detailed immunomodulatory
mechanisms were previously studied for L. rhamnosus CRL1505 (16, 20).
FIGURE S4 | Levels of intestinal interferons (IFN-β and IFN-γ), proinflammatory
cytokines (TNF-α and IL-6) and IL-10 in mice orally treated with Lactobacillus
rhamnosus CRL1505, L. rhamnosus IBL027, L. rhamnosus CRL576,
Lactobacillus plantarum CRL1506, L. plantarum MPL16, or L. plantarum CRL681
(108 cells/mouse/day for five consecutive days). Mice with no lactobacilli treatment
were used as controls. Immune factors were evaluated on day 6. The results
represent data from three independent experiments (n = 6 per group). Letters
indicate significant differences (P < 0.05), a < b < c.
FIGURE S5 | Global overview of the effect of L. rhamnosus CRL1505 and
L. plantarum MPL16 on the intestinal inflammatory injury induced by poly(I:C) and
mediated by the activation of CD3+NK1.1+CD8αα+ intraepithelial lymphocytes
(IELs) that promote epithelial destruction through the RAE1–NKG2D interaction.
Detailed immunomodulatory mechanisms were previously studied for
L. rhamnosus CRL1505 (8).
FIGURE S6 | Levels of bronco-alveolar lavages (BAL) interferons (IFN-β and
IFN-γ), TNF-α and IL-10 in mice orally treated with Lactobacillus rhamnosus
CRL1505, L. rhamnosus IBL027, L. rhamnosus CRL576, Lactobacillus plantarum
CRL1506, L. plantarum MPL16, or L. plantarum CRL681 (108 cells/mouse/day for
five consecutive days). Mice with no lactobacilli treatment were used as controls.
Immune factors were evaluated on day 6. The results represent data from three
independent experiments (n = 6 per group). Letters indicate significant differences
(P < 0.05), a < b < c.
FIGURE S7 | Levels of serum interferons (IFN-β and IFN-γ), TNF-α and IL-10 in
mice orally treated with Lactobacillus rhamnosus CRL1505, L. rhamnosus
IBL027, L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum
MPL16, or L. plantarum CRL681 (108 cells/mouse/day for five consecutive days).
Mice with no lactobacilli treatment were used as controls. Immune factors were
evaluated on day 6. The results represent data from three independent
experiments (n = 6 per group). Letters indicate significant differences
(P < 0.05), a < b < c.
FIGURE S8 | Levels of serum interferons (IFN-β and IFN-γ), TNF-α and IL-10 in
mice orally treated with Lactobacillus rhamnosus CRL1505, L. rhamnosus
IBL027, L. rhamnosus CRL576, Lactobacillus plantarum CRL1506, L. plantarum
MPL16, or L. plantarum CRL681 (108 cells/mouse/day for five consecutive days),
and then challenged by the nasal route with 250 µg of the viral molecular
associated pattern poly(I:C) for three consecutive days. Mice with no lactobacilli
treatment and challenged with poly(I:C) were used as controls. Serum immune
factors were evaluated on day 2 after the last poly(:C) administration. The results
represent data from three independent experiments (n = 6 per group). Letters
indicate significant differences (P < 0.05), a < b < c.
FIGURE S9 | Global overview of the effect of L. rhamnosus CRL1505 and
L. plantarum MPL16 on the respiratory innate immune response triggered by
poly(I:C). Detailed immunomodulatory mechanisms were previously studied for
L. rhamnosus CRL1505 (7, 9).
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